O’Rourke N., McCloskey E., Houghton F.,
è ñîàâò. Double blind, placebo con
trolled, dose response trial of oral clodronate in patients with bone metastases // J. Clin.
Oncol. — 1995. — V. 13. — P. 929 934.
Orr F.W., Kostenuik P., Sanchez+Sweatman O.H., Singh G.
Mechanisms involved in
the metastasis of cancer to bone // Breast Cancer Res. Treat. — 1993. — V. 25(2). —
P. 151 163.
Orr F.W., Sanchez+Sweatman O.H., Kostenuik P., Singh G.
Tumor bone interactions
in skeletal metastasis // Clin. Orthop. — 1995. — V.312). — P. 19 33.
Palmedo H., Bender H., Schomburg A.
Pain therapy with rhenium 186 HEDP in
multiple bone metastases // Nuklearmedizin. — 1996. — V. 35(2). — P. 63 67.
Palmedo H., Bender H., Dierke+Dzierzon C., Carl U.M., Risse J., Krebs D., Biersack
H.J.
Pain palliation with rhenium 186 HEDP in breast cancer patients with disseminated
bone metastases // Clin. Nucl. Med. — 1999. — V. 24(9). — P. 643 648.
Pannuti F., Rossi A.P., Marraro D.
è ñîàâò. The naturial history of cancer pain // In:
The Continuing Care of Terminal Cancer Patients. Eds. Twycross R.G., Ventafridda V. —
Oxford: Pergamon Press. — 1980. — P. 75 78.
Pantel K., Cote R.J., Fodstad O.
Detection and clinical importance of micrometasta
tic disease // J. Natl. Cancer. Inst. — 1999. — V. 91(13). — P. 1113 1124.
Papatheofanis F.J.
Variation in oncologic opinion regarding management of
metastatic bone pain with systemic radionuclide therapy // J. Nucl. Med. — 1999. —
V. 40(9). — P. 1420 1423.
Parazzini F., Colli E., Scatigna M., Tozzi L
. Treatment with tamoxifen and prog
estins for metastatic breast cancer in postmenopausal women: a quantitative review of pub
lished randomized clinical trials // Oncology. — 1993. — V. 50(6). — P. 483 489.
Parfitt A.M.
The physiologic and clinical significance of bone histomorphometric
data // In: Bone histomorphometry techniques. Ed. Recker R. —Boca Raton: CRC Press. —
1983. — P. 143 223.
Parkes C.M.
Accuracy in predictions of survival in later stages of cancer // Br. Med.
J. — 1972. — II — P. 29 31.
Parrish F.F., Murray J.A.
Surgical treatment for secondary neoplastic fractures. A
retrospective study of ninety six patients // J. Bone Joint Surg. — 1970. — V. 52A. —
P. 665 686.
Parvinen L.M., Numminen S.
Chemotherapy in advanced breast carcinoma.
Comparison between doxorubicin cyclophosphamide methotrexate 5 fluorouracil vin
cristine prednisone // Acta Radiol. Oncol. — 1985. — V. 24. — P.391 394.
Patanaphan V., Salazar O.M., Risco R.
Breast cancer: metastatic patterns and their
prognosis // South. Med. J. — 1988. — V. 81(9). — P. 1109 1112.
Patel S., Lyons A.R., Hosking D.J.
Drugs used in the treatment of metabolic bone
disease. Clinical pharmacology and therapeutic use // Drugs. — 1993. — V. 46. — P. 594
617.
Patel B.R., Flowers W.M.
Systemic radionuclide therapy with strontium chloride Sr
89 for painful skeletal metastases in prostate and breast cancer // South Med. J. — 1997. —
V. 90(5). — P. 506 508.
Paterson A.H., Kanis J.A., Cameron E.C., Douglas D.L., Beard J., Preston F.E.,
Russel R.G.G.
The use of dichlormethylene diphosphonate for the management of hyper
calcemia in multiple myeloma // Br. J. Haematol. — 1983. — V. 54. — P. 121 132.
Paterson A.H.
Bone metastases in breast cancer, prostate cancer and myeloma //
Bone. — 1987. — V. 8(Suppl.). — P. 17 22.
241
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
